S0688

STRUCTURE OF Bcl-XL, A DOMINANT INHIBITOR OF PROGRAMMED CELL DEATH. Steven W. Muchmore1, Micheal Sattler2, Heng Liang2, Robert P Meadows2, John E. Harlan2, David Nettesheim2, Brian Chang3, Craig B. Thompson3, Sui-Lam Wong4, Shi-Chung Ng4, Stephen W. Fesik2, 1Protein Crystallography, 2NMR Research, 3Aging and Degenerative Disease Research, Pharmaceutical Products Research Division, Abbott Laboratories Abbott Park, IL 60064, USA, 4Howard Hughes Medical Institute and Departments of Medicine, Molecula Genetics, and Cell Biology, University of Chicago, Chicago, IL 60637, USA.

The Bc1-2 family of proteins modulates programmed cell death (apoptosis) by an unknown mechanism. The structure of Bcl-XL was solved by a combination of x-ray crystallographic and NMR spectroscopic techniques. The structure consists of a total of 7 alpha-helices, two of which form a central apolar pair. The remaining helices are amphipathic and flank the central pair. A loop of approximately 60 residues connecting the first two helices was found to be both flexible and dispersible for anti- apoptotic activity. Three functionally important homology domains (BH1, BH2, BH3) are located on the same face of the molecule and form a hydrophobic cleft which may represent the interaction site for proteins which promote apoptosis. Sequence alignments of other Bc1-2 family members suggests these proteins should exhibit the same overall fold. The Bcl-XL structure is reminiscent of membrane translocation domains of bacterial toxins such as diphtheria toxin or colicin. This similarity suggests that the modulation of apoptosis by the Bcl-2, family of proteins may involve a membrane translocation event.